Applied BioCode Corporation (6598.TW)
TWD 20.35
(-0.97%)
TWD 20.35
(-0.97%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -205.08 Million | 145.87 Million | -151.77 Million | -146.74 Million | -313.83 Million | -286.71 Million |
| Net Income | -164.19 Million | -184.71 Million | -165.17 Million | -103.47 Million | -280.04 Million | -268.28 Million |
| Depreciation & Amortization | 62.68 Million | 56.51 Million | 50.95 Million | 43.59 Million | 32.8 Million | 16.63 Million |
| Deferred income taxes | -196.32 Million | - | 5.89 Million | -605 Thousand | -4.84 Million | 999 Thousand |
| Stock-based compensation | 5.54 Million | 7.72 Million | 8.56 Million | 13.53 Million | 6.88 Million | 11.16 Million |
| Change in working capital | -110.31 Million | 266 Million | -51.77 Million | -72.31 Million | -73.45 Million | -47.49 Million |
| Other non-cash items | 197.52 Million | 339 Thousand | -241 Thousand | -27.48 Million | 4.82 Million | 257 Thousand |
| Investing Cash Flow | -198.01 Million | -22.14 Million | -16.38 Million | 86.56 Million | -146.27 Million | -23.89 Million |
| Investments in PPE | -6.39 Million | -22.14 Million | -16.26 Million | -27.95 Million | -24.34 Million | -18.62 Million |
| Acquisitions | - | - | - | -383.6 Million | - | - |
| Investment purchases | -191.62 Million | - | - | 121.32 Million | -121.32 Million | -653 Thousand |
| Sales/Maturities of investments | - | - | - | 383.6 Million | - | - |
| Other Investing Activities | -191.62 Million | - | -120 Thousand | -6.8 Million | -605 Thousand | -4.61 Million |
| Financing Cash Flow | -15.7 Million | -14.85 Million | -14.18 Million | 656.76 Million | 439.24 Million | 407.66 Million |
| Debt repayment | -15.74 Million | -15.13 Million | -15.52 Million | -60.21 Million | -120.42 Million | -1000.00 |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 43 Thousand | 281 Thousand | 1.33 Million | 704.59 Million | 390.73 Million | 407.66 Million |
| Other Financing Activities | -15.74 Million | -14.85 Million | -14.18 Million | 12.37 Million | 168.93 Million | 407.66 Million |
| Accounts receivables | 19.47 Million | -3.36 Million | -24 Million | -25.37 Million | -18.42 Million | 567 Thousand |
| Accounts payables | -6.14 Million | -701 Thousand | -18.17 Million | 18.02 Million | -2.33 Million | 11.34 Million |
| Inventory | -78.74 Million | -25.89 Million | -13.38 Million | -65.56 Million | -39.69 Million | -51.26 Million |
| Other working capital | -44.9 Million | 295.96 Million | 3.78 Million | 599 Thousand | -13 Million | 3.77 Million |
| Cash at beginning of period | 831.32 Million | 646.07 Million | 847.91 Million | 302.67 Million | 349.02 Million | 247.18 Million |
| Cash at end of period | 413.19 Million | 831.32 Million | 646.07 Million | 847.91 Million | 302.67 Million | 349.02 Million |
| Capital Expenditure | -6.39 Million | -22.14 Million | -16.26 Million | -27.95 Million | -24.34 Million | -18.62 Million |
| Effect of forex changes on cash | 674 Thousand | 76.38 Million | -19.49 Million | -51.35 Million | -25.47 Million | 4.78 Million |
| Net cash flow / Change in cash | -418.12 Million | 185.25 Million | -201.84 Million | 545.23 Million | -46.35 Million | 101.84 Million |
| Free Cash Flow | -211.47 Million | 123.72 Million | -168.04 Million | -174.69 Million | -338.18 Million | -305.34 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -50 Million | -63.12 Million | -164.19 Million | -8.57 Million | -43.72 Million | -61.13 Million |
| Depreciation & Amortization | 15.32 Million | 15.45 Million | 62.68 Million | 16.06 Million | 16.05 Million | 15.58 Million |
| Deferred income taxes | - | - | -196.32 Million | -33.78 Million | 5.85 Million | 5.89 Million |
| Stock-based compensation | 415 Thousand | -3.98 Million | 5.54 Million | 1.23 Million | 1.14 Million | 1.78 Million |
| Change in working capital | 2 Million | -6.76 Million | -110.31 Million | -73.63 Million | -6.49 Million | -22.53 Million |
| Other non-cash items | 37.43 Million | 43.72 Million | 197.52 Million | 33.25 Million | -5.64 Million | -5.81 Million |
| Investing Cash Flow | -2.55 Million | 115.59 Million | -198.01 Million | 5.91 Million | -9.09 Million | -6.59 Million |
| Investments in PPE | -1.44 Million | -2.8 Million | -6.39 Million | -197.15 Thousand | -86 Thousand | -485 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | -2.21 Million | 110.97 Million | -191.62 Million | 6.11 Million | -9.01 Million | -6.11 Million |
| Sales/Maturities of investments | -1.09 Million | 110.97 Million | - | - | - | - |
| Other Investing Activities | -18.36 Thousand | 7.42 Million | -191.62 Million | 7.46 Million | -9.01 Million | -6.11 Million |
| Financing Cash Flow | -4.23 Million | -3.91 Million | -15.7 Million | -4.2 Million | -4.05 Million | -3.82 Million |
| Debt repayment | -4.15 Million | -3.99 Million | -15.74 Million | -4.12 Million | -4.05 Million | -3.82 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 855.98 | 83 Thousand | 43 Thousand | 295.55 | 105.76 | -328.46 |
| Other Financing Activities | -4.23 Million | 83 Thousand | -15.74 Million | -4.2 Million | -4.05 Million | 328.46 |
| Accounts receivables | -12.21 Million | 11.93 Million | 19.47 Million | 24.85 Million | -3.8 Million | -29.11 Million |
| Accounts payables | -1.3 Million | 614 Thousand | -6.14 Million | -24.79 Million | 14.4 Million | -330.62 Thousand |
| Inventory | 6.3 Million | -29.1 Million | -78.74 Million | -482.53 Thousand | -31.08 Million | -21.97 Million |
| Other working capital | 9.22 Million | 9.79 Million | -44.9 Million | -73.21 Million | 14 Million | 28.87 Million |
| Cash at beginning of period | 489.24 Million | 413.19 Million | 831.32 Million | 499.97 Million | 526.55 Million | 590.57 Million |
| Cash at end of period | 455.44 Million | 489.24 Million | 413.19 Million | 413.19 Million | 499.97 Million | 526.55 Million |
| Capital Expenditure | -1.44 Million | -2.8 Million | -6.39 Million | -197.15 Thousand | -86 Thousand | -485 Thousand |
| Effect of forex changes on cash | 6.23 Million | 22.54 Million | 674 Thousand | -25.6 Million | 19.37 Million | 12.63 Million |
| Net cash flow / Change in cash | -33.8 Million | 76.04 Million | -418.12 Million | -86.78 Million | -26.58 Million | -64.01 Million |
| Free Cash Flow | -34.55 Million | -60.98 Million | -211.47 Million | -65.63 Million | -32.89 Million | -66.7 Million |
CRH
BFT
2428
5347
VALUE
HSTXF